Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, South Korea.
Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, South Korea.
Eur Radiol. 2021 Nov;31(11):8606-8614. doi: 10.1007/s00330-021-07955-1. Epub 2021 Apr 21.
To validate the functional liver imaging score (FLIS) for prediction of hepatic function in gadoxetic acid-enhanced MRI.
We retrospectively identified 134 patients (88 men, 46 women; mean age, 58.8 years) between January 2015 and December 2018 with the following inclusion criteria: patients diagnosed with liver cirrhosis or chronic liver disease (CLD) who underwent gadoxetic acid-enhanced MRI. Three parameters on hepatobiliary phase images were evaluated for FLIS: liver parenchymal enhancement, biliary excretion, and signal intensity of the portal vein. Patients were classified as CLD (n = 11), Child-Pugh (CP) class A (n = 87), CP B (n = 22), or CP C (n = 14). We assessed the correlation between CP score and both FLIS and its components using Spearman rank correlation. Receiver operating characteristic (ROC) curve analysis was performed to demonstrate the cutoff value of FLIS for differentiating between CP classes. The associations between patient characteristics, serum markers, FLIS, and hepatic decompensation were evaluated with Cox proportional hazard models.
FLIS and three FLIS parameters showed strong to very strong correlation with CP score (r = -0.60 to 0.82). ROC curve analysis showed that FLIS ≥ 5 was the optimal cutoff for prediction of CP class A or CLD (sensitivity, 83.7%; specificity, 94.4%; area under the curve [AUC], 0.93). FLIS < 5 was independently associated with the development of first hepatic decompensation in patients with CP A (HR, 50.0; 95% confidence interval, 6.2, 400.4).
FLIS showed a strong correlation with hepatic function and can stratify the CP class. In addition, FLIS can help prediction for the development of first decompensation.
• Functional liver imaging scores (FLIS) and its three parameters, derived from hepatobiliary phase image, have strong to very strong correlations with Child-Pugh (CP) scores. • FLIS can stratify patients with chronic liver disease or liver cirrhosis according to CP classification. • Low FLIS is an independent predictor for first hepatic decompensation in patients with CP class A.
验证功能肝脏成像评分(FLIS)在钆塞酸增强 MRI 中预测肝功能的价值。
我们回顾性纳入了 2015 年 1 月至 2018 年 12 月期间因肝硬化或慢性肝病(CLD)行钆塞酸增强 MRI 的 134 例患者(88 例男性,46 例女性;平均年龄 58.8 岁)。纳入标准为:患者存在肝脏实质增强、胆汁排泄和门静脉信号强度等 3 项肝胆期图像参数的评估指标。将患者分为 CLD(n = 11)、Child-Pugh(CP)A级(n = 87)、CP B 级(n = 22)或 CP C 级(n = 14)。采用 Spearman 秩相关评估 CP 评分与 FLIS 及其组成部分之间的相关性。通过绘制受试者工作特征(ROC)曲线,确定 FLIS 区分 CP 分级的截断值。采用 Cox 比例风险模型评估患者特征、血清标志物、FLIS 与肝失代偿之间的相关性。
FLIS 及其 3 项参数与 CP 评分呈强至极强相关(r = -0.60 至 0.82)。ROC 曲线分析显示,FLIS≥5 是预测 CP A 级或 CLD 的最佳截断值(敏感性为 83.7%,特异性为 94.4%,曲线下面积 [AUC]为 0.93)。FLIS<5 与 CP A 级患者首次肝失代偿的发生独立相关(HR,50.0;95%置信区间,6.2,400.4)。
FLIS 与肝功能具有很强的相关性,可对 CP 分级进行分层。此外,FLIS 有助于预测首次失代偿的发生。
•FLIS 及其三个参数来源于肝胆期图像,与 CP 评分具有强至极强相关性。•FLIS 可根据 CP 分级对慢性肝病或肝硬化患者进行分层。•低 FLIS 是 CP A 级患者首次肝失代偿的独立预测因素。